Title

RE: Colchicine and risk of hospitalization due to COVID‐19: A population‐based study.

Authors

Sáenz‐Aldea, María; Salgado‐Barreira, Ángel; Taracido‐Trunk, Margarita; Piñeiro‐Lamas, María; Herdeiro, Maria T.; Portela‐Romero, Manuel; Saez, Marc; Figueiras, Adolfo

Abstract

We have read with interest the comments made by Chang and Gau[1] concerning the complicated interaction between colchicine and COVID-19, and potential biases due to the severity of gout and the comorbidity status of neurological diseases. However, since our data were sourced from electronic medical records, information on the indication for colchicine treatment, gout status and severity, and uric acid levels was not available. We agree with Chang and Gau on the interest attaching to the possible influence of gout severity on COVID-19 severity and progression.

Subjects

COLCHICINE; COVID-19

Publication

Journal of Medical Virology, 2023, Vol 95, Issue 4, p1

ISSN

0146-6615

Publication type

Academic Journal

DOI

10.1002/jmv.28741